Holen Sie sich die Stockscreener-App
11.62
3.21%
0.36
Schlusskurs vom Vortag:
$11.26
Offen:
$11.28
24-Stunden-Volumen:
5.25M
Relative Volume:
1.88
Marktkapitalisierung:
$915.13M
Einnahmen:
$65,400
Nettoeinkommen (Verlust:
$-46.34M
KGV:
-12.63
EPS:
-0.92
Netto-Cashflow:
$-38.74M
1W Leistung:
+18.82%
1M Leistung:
+8.00%
6M Leistung:
-19.02%
1J Leistung:
+24.29%
1-Tages-Spanne:
$11.09
$12.10
1-Wochen-Bereich:
$9.75
$12.10
52-Wochen-Spanne:
$5.60
$17.43
CorMedix Inc Stock (CRMD) Company Profile
Firmenname
CorMedix Inc
Sektor
Branche
Telefon
908-517-9500
Adresse
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Vergleichen Sie CRMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
11.62 | 887.16M | 65,400 | -46.34M | -38.74M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.92 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
699.15 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.13 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.47 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.88 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Hochstufung | D. Boral Capital | Hold → Buy |
| 2025-06-30 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2025-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-07 | Eingeleitet | Leerink Partners | Outperform |
| 2025-01-13 | Eingeleitet | D. Boral Capital | Buy |
| 2024-08-26 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-08-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-02-17 | Eingeleitet | Needham | Buy |
| 2020-09-29 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-09-21 | Eingeleitet | Truist | Buy |
| 2019-12-18 | Eingeleitet | B. Riley FBR | Buy |
| 2019-03-26 | Bestätigt | H.C. Wainwright | Buy |
| 2018-12-06 | Eingeleitet | ROTH Capital | Buy |
| 2017-09-25 | Bestätigt | H.C. Wainwright | Buy |
| 2017-08-10 | Bestätigt | Rodman & Renshaw | Buy |
| 2017-05-05 | Bestätigt | Rodman & Renshaw | Buy |
| 2016-11-11 | Bestätigt | FBR & Co. | Outperform |
| 2016-03-17 | Bestätigt | FBR Capital | Outperform |
| 2016-03-03 | Eingeleitet | FBR Capital | Outperform |
| 2015-11-16 | Bestätigt | ROTH Capital | Neutral |
| 2015-10-29 | Bestätigt | ROTH Capital | Neutral |
| 2015-05-06 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2014-12-08 | Bestätigt | ROTH Capital | Buy |
| 2011-10-03 | Herabstufung | Maxim Group | Buy → Hold |
Alle ansehen
CorMedix Inc Aktie (CRMD) Neueste Nachrichten
Does CorMedix (CRMD) Have the Potential to Rally 68.74% as Wall Street Analysts Expect? - Yahoo Finance
CorMedix (CRMD) Upgraded to Strong Buy: Here's What You Should Know - sharewise.com
Best Value Stocks to Buy for December 8th - Zacks Investment Research
New Strong Buy Stocks for December 8th - Zacks Investment Research
CorMedix Shares Garner Strong Analyst Confidence Following Robust Earnings - AD HOC NEWS
Can DefenCath Continue to Aid CorMedix's Long-Term Growth Ahead? - sharewise.com
CorMedix director Dillione sells $466k in shares By Investing.com - Investing.com Nigeria
Is CorMedix Stock Still Attractive After Strong Multi Year Gains And Recent Volatility In 2025 - Yahoo Finance
CorMedix director Dillione sells $466k in shares - Investing.com
Is CorMedix (NASDAQ:CRMD) Using Too Much Debt? - 富途牛牛
How (CRMD) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Deep Track Capital, LP's Strategic Acquisition of Cormedix Inc Shares - GuruFocus
Will CorMedix Inc. (19KA) stock benefit from sector leadershipBuy Signal & Reliable Volume Spike Trade Alerts - Newser
Is CorMedix Inc. stock supported by innovation pipelineQuarterly Profit Report & Risk Managed Investment Entry Signals - Newser
Will CorMedix Inc. (19KA) stock see insider accumulationLong Setup & Accurate Entry/Exit Alerts - Newser
Should I buy CorMedix Inc. (19KA) stock before earnings seasonJuly 2025 Earnings & Daily Stock Trend Reports - Newser
Can CorMedix Inc. stock sustain revenue growthWeekly Profit Summary & Consistent Return Investment Signals - Newser
Will CorMedix Inc. stock see PE expansionRate Cut & High Accuracy Trade Signal Alerts - Newser
Cormedix (CRMD) Stock Analysis Report | Financials & Insights - Benzinga
Is CorMedix Inc. stock a bargain at current levelsTrade Entry Report & Short-Term Trading Opportunity Alerts - Newser
Would You Still Hold Cormedix Stock If It Fell Another 30%? - Trefis
Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance - MSN
Pharming Group Posts Upbeat Q3 Results, Joins On Holding, BigBear.ai Holdings And Other Big Stocks Moving Higher On Wednesday - Sahm
CorMedix director Dillione sells $261,585 in CRMD stock By Investing.com - Investing.com Australia
At Cormedix, Janet Dillione Chooses To Exercise Options, Resulting In $158K - Benzinga
CorMedix director Dillione sells $261,585 in CRMD stock - Investing.com India
CorMedix Director Janet Dillione Sells 26,343 Shares - TradingView
Dir Dillione Sells 26,343 ($261.6K) Of CorMedix Inc [CRMD] - TradingView
CorMedix (CRMD) Is Down 6.3% After Strong Q3 Results and $87.6M Shelf Registration Filed - simplywall.st
What drives CorMedix Inc stock priceAnalyst Downgrades & Small Capital Trading Plans - earlytimes.in
Assessing CorMedix (CRMD): Is the Current Share Price Reflecting Its True Value? - Yahoo Finance
Dir Dillione Files To Sell 73,000 Of CorMedix Inc [CRMD] - TradingView
H.C. Wainwright Raises the PT on CorMedix Inc. (CRMD), Keeps a Buy - MSN
American Kidney Fund Hosts Third Patient Access Initiative Summit to Address Barriers to Kidney Care and Propose Innovative Solutions - GlobeNewswire Inc.
Will CorMedix Inc. (19KA) stock deliver compounding returns2025 Technical Patterns & Growth Focused Stock Pick Reports - newser.com
How institutional buying supports CorMedix Inc. stockJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - newser.com
Cormedix Inc (CRMD) Q3 2025 Earnings Call Highlights: Record Financial Performance and ... By GuruFocus - Investing.com Canada
Why CorMedix Inc. (19KA) stock attracts HNW investorsTrend Reversal & High Conviction Trade Alerts - newser.com
CorMedix Stock Hits Day Low of $9.82 Amid Price Pressure - Markets Mojo
How CorMedix Inc. (19KA) stock stacks up against competitorsJuly 2025 Decliners & Reliable Volume Spike Trade Alerts - newser.com
How big funds are accumulating CorMedix Inc. (19KA) stockPortfolio Performance Report & Real-Time Stock Movement Alerts - newser.com
How CorMedix Inc. stock performs in rising dollar environmentMarket Activity Report & Low Risk Entry Point Guides - newser.com
Will CorMedix Inc. stock benefit from green energy trendsJuly 2025 Intraday Action & Daily Profit Focused Screening - newser.com
Should I hold or sell CorMedix Inc. stock in 2025Market Trend Summary & AI Forecast Swing Trade Picks - newser.com
What institutional flow reveals about CorMedix Inc.Weekly Investment Summary & Low Risk Entry Point Guides - newser.com
Will CorMedix Inc. (19KA) stock outperform value peersMarket Movers & Real-Time Buy Zone Alerts - newser.com
Is CorMedix Inc. reversing from oversold territory2025 Performance Recap & Community Trade Idea Sharing - newser.com
Finanzdaten der CorMedix Inc-Aktie (CRMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):